Data for comparative proteomics analysis of the antitumor effect of CIGB-552 peptide in HT-29 colon adenocarcinoma cells
CIGB-552 is a second generation antitumor peptide that displays potent cytotoxicity in lung and colon cancer cells. The nuclear subproteome of HT-29 colon adenocarcinoma cells treated with CIGB-552 peptide was identified and analyzed [1]. This data article provides supporting evidence for the above...
Main Authors: | Núñez de Villavicencio-Díaz, Teresa, Ramos Gómez, Yassel, Oliva Argüelles, Brizaida, Fernández Masso, Julio R., Rodríguez-Ulloa, Arielis, Cruz García, Yiliam, Guirola-Cruz, Osmany, Perez-Riverol, Yasset, Javier González, Luis, Tiscornia, Inés, Victoria, Sabina, Bollati-Fogolín, Mariela, Besada Pérez, Vladimir, Guerra Vallespi, Maribel |
---|---|
Format: | Online |
Language: | English |
Published: |
Elsevier
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534583/ |
Similar Items
-
Proteomic Study to Survey the CIGB-552 Antitumor Effect
by: Rodríguez-Ulloa, Arielis, et al.
Published: (2015) -
The Antitumor Peptide CIGB-552 Increases COMMD1 and Inhibits Growth of Human Lung Cancer Cells
by: Fernández Massó, Julio R., et al.
Published: (2013) -
HT-29 and Caco-2 Reporter Cell Lines for Functional Studies of Nuclear Factor Kappa B Activation
by: Mastropietro, Giuliana, et al.
Published: (2015) -
Optimizing CIGB-300 intralesional delivery in locally advanced cervical cancer
by: Sarduy, M R, et al.
Published: (2015) -
Open source libraries and frameworks for biological data visualisation: A guide for developers
by: Wang, Rui, et al.
Published: (2015)